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Abstract
Background: The purpose of this study is to assess the relationship between self-reported uveitis and purported
demographic and clinical risk factors, using an American adult population extracted from the National Health
and Nutrition Examination Survey (NHANES) for the years 2009 and 2010. This is a cross-sectional, population-based
study using a sample of 5106 subjects between 20 and 69 years old. The main outcome for our study was the self-
report of a diagnosis of uveitis. The demographic analysis included age, gender, and ethnicity. Potential
predictors were having a diagnosis of ankylosing spondylitis (AS), ulcerative colitis (UC), or Crohn’s disease
(CD); a history of cigarette smoking; vitamin D deficiency; and different mental health measures. Univariate
and multivariate analyses were conducted using RStudio.
Results: Of the 5106 participants, 27 had reported a diagnosis of uveitis, showing an adjusted prevalence
of 5.4 per 1000 subjects (95% CI 3.4–8.5/1000). Increased age was associated with higher uveitis prevalence
in the multivariate analysis (odds ratio [OR] = 1.04, 95% CI 1.01–1.07; p = 0.02). Positive smoking history was
reported in 59.2% of patients. Multivariate analysis comparing smoking with the presence of uveitis showed
an OR of 3.18 (95% CI 1.59–6.37; p = 0.003), adjusting for age and gender. Moreover, 11.1% of the participants
from the uveitis group self-reported a diagnosis of AS and 11.7% informed a diagnosis of UC and 7.1% of
CD. The ORs were of 16.64 (95% CI 3.64-76.09; p = 0.001), 11.34 (95% CI 2.69-47.88; p = 0.003), and 22.16 (95%
CI 2.64-186.17; p = 0.007), respectively when compared with the non-uveitis group in the multivariate analysis.
Conclusions: Age, cigarette smoking, AS, UC, and CD are positively associated with self-reported uveitis. There is previous
evidence that smoking and female gender are positive risk factors for uveitis, as well as evidence that HLA-B27-positive
spondyloarthritides have the highest association with non-infectious uveitis in the adult population in North America and
Europe. However, there are no prior studies that have utilized a representative US population-based sample to validate these
findings. The present study supports smoking as a risk factor, which has clinical relevance since this is a modifiable habit.
Keywords: Epidemiology, Uveitis, Prevalence, Cigarette smoking, Arthritis, Ankylosing spondylitis, Ulcerative colitis, Crohn’s
disease
Background
Uveitis is a sight-threatening inflammatory disease af-
fecting the uveal layer of the eye. It is responsible for an
estimated 30,000 new cases of legal blindness annually
in the USA [1, 2] and accounts for about 10–15% of all
cases of total blindness in the country [1, 3, 4].
Approximately 30% of cases of uveitis are idiopathic
and have an unknown etiology [3, 5–7]. On the other
hand, an underlying systemic illness is estimated to
cause 25 to 50% of the cases, resulting in a non-
infectious uveitis, which is more common in developed
countries compared with the infectious type [3, 8–12].
Among the non-infectious forms of uveitis, patients’
demographics strongly influence the distribution and
prevalence of disease. The HLA-B27-positive spondy-
loarthritides, such as ankylosing spondylitis (AS), react-
ive arthritis (ReA), enteropathic arthropathy (EnA), and
psoriatic arthritis (PsA), are the most common systemic
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immune disorders associated with anterior uveitis in the
adult population in North America and Europe [5, 13–
15]. Other disorders known to be associated with uveitis
are Behçet’s disease, sarcoidosis, systemic lupus erythe-
matosus, and multiple sclerosis [5, 16].
Risk factors for the development of uveitis have been
previously reported. It is well established that there is a
higher incidence in women compared with men [17]
and that the risk increases with older age [17, 18], al-
though the later has not been uniformly supported by
studies [1, 10, 14, 18–23]. Smoking has also been re-
cently reported to be positively associated with the de-
velopment of uveitis [24, 25], as well as being a risk
factor for active disease [26]. A positive correlation has
also been observed between vitamin D deficiency and
non-infectious uveitis [27, 28].
The National Health and Nutrition Examination Survey
(NHANES) is a program of studies designed to assess the
health and nutritional status of adults and children in the
USA that has been validated and widely used for different
disease analyses [29, 30]. In ophthalmology, NHANES has
provided epidemiological data on macular degeneration,
glaucoma, and refractive errors [31–34].
Previous studies have assessed the epidemiology of
uveitis in the USA. One of them was based on insurance
companies’ information and focused on non-infectious
uveitis, and the other one included only a population
sample from a specific area in California [12, 18]. The
significant advantages of a NHANES-based study are the
use of the survey data to produce representative results
of the entire US population and the ability to examine
potential demographic and clinical risk factors for uveitis
at a nationwide level.
The purpose of our present study is to determine the
association between self-reported uveitis in an adult
American population and potential demographic and
clinical risk factors, as well as the prevalence of the
disease in the USA, using a nationwide database.
Results
From the 5106 interviewed US residents, 27 self-
reported a diagnosis of uveitis, indicating a prevalence of
the disease of 5.4/1000 (95% CI 3.4–8.5/1000) in our
adult American population within an age range of 20 to
69 years old. Out of the subjects with self-reported
uveitis (n = 27), 19 (70%) reported having received treat-
ment. The demographic characteristics of the uveitis
group compared with the non-uveitis group can be
found in Table 1. The results of the multivariate analysis
are shown in Table 2.
Of the 27 participants with uveitis, 63% were female
and 37% were male, compared with 51.5% of females in
the non-uveitis group. The OR for female sex using
multivariate analysis was of 2.07 (95% CI 0.79–5.44; p
= 0.1). The mean age for the uveitis population was of
53 ± 13 years and 44 ± 14 years for the non-uveitis one.
This difference showed an OR in years of age of 1.04
(95% CI 1.01–1.07; p = 0.02) by multivariate analysis, in-
dicating higher odds of uveitis with greater age.
The ethnic distribution included 8 Hispanics (29.6%), 10
Caucasians (37%), 6 African Americans (22.2%), and 3
Others (11.1%) in the uveitis group. No significant associ-
ation was found for any specific subgroup neither in the
univariate nor in the multivariate analysis when compared
with the non-uveitis group.
With regard to the presence of different spondyloar-
thropathies, 3 patients (11.1%) from the uveitis group
self-reported a diagnosis of AS, in comparison with 26
(0.5%) from the non-uveitis group. In both the univariate
and multivariate analyses, we found that the presence of
a diagnosis of AS in the uveitis group was statistically
significant (p ≤ 0.001), with an OR of 16.64 (95% CI
3.64–76.09) using multivariate analysis. Equally signifi-
cant was the presence of UC and CD among the partici-
pants with uveitis, with 3 (11.7%) and 2 (7.1%) reporting
each diagnosis, respectively. The OR of the multivariate
analysis was 11.34 (95% CI 2.69–47.88; p = 0.003) for
UC and 22.16 (95% CI 2.64–186.17; p = 0.007) for CD.
Sixteen (59.2%) out of the 27 uveitis participants reported
having smoked at least 100 cigarettes in their lifetime, com-
pared with 2292 (44.9%) from the non-uveitis group. The
multivariate analysis for a positive smoking history in the
uveitis group, adjusting for age and sex, showed an OR of
3.18 (95% CI 1.59–6.37; p = 0.003), using non-smokers as the
comparator. Of the 16 participants with a positive smoking
history from the uveitis group, 6 (37.5%) were current
smokers and 10 (62.5%) former smokers, leaving just 11
(40.7%) never smokers. In the non-uveitis group, those num-
bers were 1266 (24.8%) for the current smokers, 1026
(20.1%) for the former smokers, and 2814 (55.1%) for the
never smokers. Multivariate analysis of smoking status in the
uveitis group demonstrated that former smokers had higher
odds of uveitis than current smokers when compared with
non-smokers, with an OR of 4.26 (95% CI 2.19–8.26; p
< 0.001) and 1.97 (95% CI 0.59–6.52; p= 0.25), respectively.
Subanalyses for mental health and stress values did
not show any statistically significant result, with 48.2%
of the participants with diagnosed uveitis reporting poor
mental health for at least 1 day during the past 30 days
(p = 0.5) and 77.8% reporting anxiety or worriedness for
at least 1 day during the past 30 days (p = 0.3). Likewise,
educational level and annual household income were not
found to have any association with a diagnosis of uveitis,
with p values of 0.2 and 0.4, respectively.
Vitamin D levels (25-dehydroxyvitamin D2 + D3) were
measured in serum samples, and 25 out of the 27 patients
with uveitis had the laboratory test performed. None of
the 25 patients were found to have values indicative of
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deficiency (less than or equal to 30 nmol/L). The mean
levels for vitamin D in the uveitis group were 65.3 ±
25 nmol/L and 61.6 ± 25 nmol/L in the non-uveitis group
(p = 0.7).
Discussion
In our US population-based study using the NHANES
database, we found that AS, cigarette smoking, and
higher age were positively associated to self-reported
uveitis. Its main strengths include the wide diversity of
the database in terms of geographic characteristics and
socioeconomic status and its representation of the
national noninstitutionalized population, making it the
first nationwide study in the country comparing the
presence of self-reported uveitis with different demo-
graphic and clinical factors.
For our analysis, we looked at known risk factors for
the development of uveitis, such as, UC, and CD. It has
been previously reported that HLA-B27-positive spondy-
loarthritides have the highest association with non-
infectious uveitis in the adult population in North Amer-
ica and Europe [5, 13–15]. In our study, we found a sta-
tistically significant predominance of all three diagnoses
in the uveitis group compared with the non-uveitis
group, which supports the results from the previous
literature.
Given that all analyses on our population-based study
accounted for the multi-stage nature of NHANES, these
results are nationally representative, and thus, we can
extrapolate them in order to obtain an estimate of the
actual prevalence of the disease in the country, which is
of 5.4 per 1000 residents (95% CI 3.4–8.5/1000). This
number differs from previous epidemiologic studies car-
ried out by Thorne et al. [12] and Gritz and Wong [18],
who reported an overall prevalence of 121 cases per
100,000 adults (95% CI 117.5–124.3) in the USA and
115.3 per 100,000 persons in Northern California, re-
spectively. If we would only consider the patients from
our database who reported having received treatment
for uveitis (n = 19) as a way of confirming their diagno-
ses, the prevalence estimate in our population would still
be higher than those previously mentioned (3.4/1000
persons; 95% CI 2.3–5.1/1000). A possible explanation
could be that our study is not limited to a specific type
of uveitis, as it is the one from Thorne et al., which
mainly looked at the prevalence of noninfectious uveitis,
and that it is based on the national population, as op-
posed to Gritz and Wong’s study, which may give more
regional results based on Northern California popula-
tion, and Thorne et al., who only studied privately in-
sured patients, excluding an important part of society.
Also, those two studies calculated the prevalence of the
disease during a 1-year period, while we measured the
lifetime prevalence of the participants, so age may be
playing a role in this prevalence estimate as a risk factor
for the disease.
Prior studies have shown that ocular inflammatory dis-
orders have a higher incidence in women compared with
men, particularly in women of childbearing age, and that
this gender difference increases with increasing age [17].
Sex hormones and the presence of an extra X chromo-
some in women are thought to play important roles in
the development of these immune-mediated diseases
[17, 35, 36]. While this gender difference has been found
in studies performed in several developed countries [5,
6], a reverse gender predilection has been noted in de-
veloping countries, such as India or Turkey, where a
male predominance was found [14, 15, 19–21]. In our
study which examined residents in the USA, a slight fe-
male predominance was found, although it was not sta-
tistically significant.
As previously mentioned, a positive association be-
tween age and the development of uveitis was found in
our analysis, where the greater the age, the higher the
odds of suffering from uveitis. This finding supports re-
sults obtained in the Pacific Ocular Inflammation Study
carried out in a Hawaiian population and Gritz and
Wong’s Northern California Epidemiology of Uveitis
Study [1, 18]. Several other studies have reported the
highest incidence of uveitis in persons between the ages
of 20 and 40 years [10, 14, 19–23]. This differs from our
results, which showed a higher mean age of 53 ± 13 years
old, with most of the patients concentrated between the
ages of 40 to 60 years. However, our population partici-
pated in a survey that asked “Have you ever been diag-
nosed with uveitis?”, which may be the reason for this
discordance, since the older the participants, the higher
the chance for them to have had uveitis in the past. The
age of diagnosis was not an available variable on the
dataset. Although age has been a risk factor that has not
been unanimously related with uveitis, our study adds
evidence of age being a related risk factor in a large-
scale population-based study.
Our analysis of ethnicity did not reveal any specific
ethnic group predominance, which may be partly due to
the small sample size or a true lack of correlation. Our
results contrast with other studies that have shown slight
group differences, including the Pacific Ocular Inflam-
mation Study which found a higher incidence of uveitis
in the white population when compared with Asians and
Pacific Islanders [1]. Furthermore, Nguyen et al. reported
a higher incidence of uveitis in African American pa-
tients with inflammatory bowel disease in comparison
with Caucasian patients [37].
A link between vitamin D deficiency status and uveitis
has also been previously reported. A study done in
China in 2010 looking at patients with Vogt–Koyanagi–
Harada (VKH) disease described a possible association
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between VKH and vitamin D deficiency [28]. A more
recent study carried out in the Massachusetts Eye and
Ear Infirmary determined that there is a correlation be-
tween vitamin D deficiency and non-infectious uveitis
[27]. All patients in our study population had normal
levels of vitamin D in serum samples, which differs from
the results of these two previous studies.
Our present study also demonstrates that a positive
history of cigarette smoking is associated with higher
odds of a uveitis diagnosis. This higher rate of uveitis
was obtained through the former smokers’ group, lead-
ing us to theorize that patients stopped smoking when
they were diagnosed with the disease due to their
doctor’s recommendation. This association between uve-
itis and tobacco smoking supports the results obtained
by Lin et al., who concluded that cigarette smoking is a
risk factor for all anatomic types of uveitis as well as in-
fectious uveitis, and Yuen et al., who found that cigarette
smoking had a strong association mainly with noninfec-
tious uveitis [24, 25]. It has also been found that tobacco
Table 1 Demographic and clinical characteristics of the population
Characteristic No self-reported uveitis
(n = 5106)
Self-reported uveitis
(n = 27)
p valuea
Age mean (years) ± standard deviation 44 ± 14 53 ± 13 < 0.001*
Female sex (n (%)) 2630 (51.5) 17 (63.0) 0.2
Ethnicity (n (%))
Mexican 1031 (20.2) 2 (7.4) 0.1
Other Hispanic 572 (11.2) 6 (22.2)
Non-Hispanic white 2247 (44.0) 10 (37.1)
Non-Hispanic black 960 (18.8) 6 (22.2)
Others 296 (5.8) 3 (11.1)
Spondyloarthropathies (n (%))
Ankylosing spondylitis 26 (0.5) 3 (11.1) < 0.001*
Enteropathic arthritis (UC) 46 (0.9) 3 (11.7) 0.002**
Enteropathic arthritis (CD) 15 (0.3) 2 (7.1) 0.002**
Smoking status (n (%))
Current smoker 1266 (24.8) 6 (22.2) 0.1
Former smoker 1026 (20.1) 10 (37.0)
Never smoker 2814 (55.1) 11 (40.7)
Current health status (n (%))
Mental health not good past 30 daysb 2798 (54.8) 13 (48.2) 0.5
Felt anxious past 30 daysc 3533 (69.2) 21 (77.8) 0.3
Educational level (n (%))
Less than 9th grade 463 (10.3) 1 (4.5) 0.2
9th grade to less than high school graduate 687 (15.3) 4 (18.2)
High school graduate or GED equivalent 1044 (23.2) 4 (18.2)
Some college 1335 (29.6) 4 (18.2)
College graduate and beyond 973 (21.6) 9 (40.9)
Annual house income (n (%))
< US$20,000/year 958 (21.3) 2 (9.1) 0.4
US$20,000–44,999/year 1422 (31.6) 10 (45.5)
US$45,000–74,999/year 893 (19.8) 5 (22.7)
≥ US$75,000/year 1229 (27.3) 5 (22.7)
aAll p values are unadjusted. p values were calculated using the Wald test for continuous variables and the design-adjusted Rao–Scott–Pearson χ2 test for
categorical variables
bFor how many days during the past 30 days was your mental health not good (which includes stress, depression, and problems with emotions)?
cDuring the past 30 days, for about how many days have you felt worried, tense, or anxious? (Any number of days reported in these two questions was
considered to be a positive finding)
*Significant at the 0.001 probability level
**Significant at the 0.01 probability level
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smokers have a higher risk for active disease, the need
for higher doses of steroids in order to control their
uveitis, an earlier development of the disease, higher in-
cidence of bilateral ocular inflammation, higher odds of
disease recurrence, and higher rates of cystoid macular
edema as a complication [26, 38, 39]. This positive
association between tobacco smoking and uveitis, how-
ever, may not apply to all forms of uveitis because
tobacco smoking does not have any negative ocular
effects in patients with Behçet’s disease [40].
Cigarette smoking is the leading preventable cause of
death in the USA [41]. It causes more than 480,000 deaths
each year in the USA and accounts for nearly one in five
deaths [41–43]. Chronic exposure to tobacco smoke or
nicotine has an effect on the immune system, increasing
the release of pro-inflammatory cytokines such as TNF-α,
IL-1, IL-6, IL-8, and GM-CSF, as well as decreasing the re-
lease of anti-inflammatory ones, such as IL-10. These
findings support the theories that cigarette smoking has a
positive correlation with the development of many
chronic inflammatory and autoimmune diseases, although
the causal and pathophysiological relationship still re-
mains unclear [44–51].
Despite the advantages of using such a large database,
our study has several limitations intrinsic of the
NHANES design. Some of these weaknesses are the
small sample size of those with uveitis, which may have
underpowered the study and thus prevent us from iden-
tifying well-known disease predictors, such as gender;
the fact that it is generalizable only to the noninstitu-
tionalized US residents, excluding the institutionalized
population in the country; and the cross-sectional nature
of the study, which precludes the analysis of the
pathology over time. This can also lead to an overesti-
mation of the prevalence and risk factors.
Moreover, self-report of uveitis by the participants may
refer to either an acute isolated attack or to chronic dis-
ease, which is not specified in the questionnaires. The
questionnaire also does not ask the participants to specify
the location of the uveitis (anterior, intermediate, poster-
ior, or panuveitis). It is also possible that, since the diagno-
sis of uveitis was not verified by an ophthalmologist,
patients may have confused their diagnosis with other
types of eye inflammation. The fact that only 19 out of 27
patients with uveitis reported having received treatment
raises suspicion on the accuracy of the diagnosis, since it
is not the standard of care to leave uveitis untreated. On
the other hand, uveitis may not have been diagnosed in all
participants. Some participants may not have been aware
of a uveitis episode and therefore not reported it. There-
fore, recall bias may influence the results and add more
uncertainty to the prevalence estimate. A study published
in 1991 suggested that self-reported ocular disease should
not be the only source of information for prevalence esti-
mates and that clinical determinations are necessary [52],
and a more recent paper trying to determine the validity
of self-reported eye disease in a Latino population con-
cluded that the sensitivity is generally very low, so there is
a high chance that patients who did not report the disease
actually had it, while the specificity was high for all the
diagnoses [53]. However, none of these two studies asked
for a diagnosis of uveitis, and only self-reported cataract,
glaucoma, diabetic retinopathy or macular degeneration
were studied. There is no evidence in the literature of the
validity of self-reported uveitis for epidemiologic studies.
Other limitations of the study may be that when look-
ing at the smoking history, we just focused on the gen-
eral categories of whether patients were never, former,
or current smokers; we did not evaluate specific quan-
tities such as number of cigarettes smoked per day, years
of smoking, or the timing of smoking in relation to the
diagnosis of uveitis; and the fact that correlation between
two variables does not prove causation [54, 55]. More-
over, the 95% confidence intervals of multivariable
models were wide, indicating that there may be some
imprecision in the effect estimates.
Conclusions
In summary, our analysis of a sample of the US adult
population extracted from the NHANES database identi-
fied a positive association between self-reported uveitis
and the presence of AS, UC, and CD, a positive smoking
history, and higher age. Further prospective and longitu-
dinal studies and investigations with different
demographic populations would aid in our understand-
ing of the roles of these risk factors in the development
of uveitis.
Table 2 Multivariate analysis of self-reported uveitis in the
arthritis population
Variable OR 95% CI p value
Age 1.04 (1.01–1.07) 0.02
Female sex 2.07 (0.79–5.44) 0.13
Ethnicitya 1.92 (0.69–5.33) 0.20
Ever smoker 3.18 (1.59–6.37) 0.003**
Never smoker 1.00
Former smoker 4.26 (2.19–8.26) < 0.001*
Current smoker 1.97 (0.59–6.52) 0.25
Ankylosing spondylitis 16.64 (3.64–76.09) 0.001*
Ulcerative colitis 11.34 (2.69–47.88) 0.003**
Crohn’s disease 22.16 (2.64–186.17) 0.007**
Mental health 1.02 (0.96–1.07) 0.55
Anxiety 1.04 (0.99–1.09) 0.12
Multivariate variable is corrected for age and gender
aReference group for ethnicity: non-Hispanic whites
*Significant at the 0.001 probability level
**Significant at the 0.01 probability level
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Methods
NHANES database analysis
For our study, we used a sample of the US population
extracted from the database of the NHANES for the years
2009 and 2010. The NHANES is a source of cross-
sectional information about the health and nutritional
status of the American population obtained through
questionnaires about demographics, socioeconomic status,
diet, and health, as well as physical examination. The
survey examines approximately 5000 persons each year in
counties across the USA. It is a major program of the
National Center for Health Statistics (NCHS) and is
administered by the Centers for Disease Control and
Prevention (CDC) in order to provide US health statistics.
It uses a complex, multistage probability sampling
design in order to select a sample representative of the ci-
vilian noninstitutionalized household population of the
country. A weighting scheme is applied in order to more
accurately estimate disease prevalence in the USA [56].
Since this research uses publicly available de-identified
data, it is considered exempt from the Committee for
Human Research approval by the University of California,
San Francisco.
We analyzed the data to assess the association be-
tween self-reported uveitis and various demographic and
clinical data. The sample consisted of 5106 American
residents between the ages 20 and 69 years old who were
asked for a diagnosis of uveitis through the question
“Has a doctor or other health professional ever told you
that you had iritis or uveitis?” Predictor values for that
population group were the presence of a diagnosis of
AS, UC, or CD, assessed by the questions, “Has a doctor
or other health professional ever told you that you had
ankylosing spondylitis/ulcerative colitis/Crohn’s dis-
ease?”; ethnicity (Mexican, other Hispanic, non-Hispanic
white, non-Hispanic black, and Others); smoking history
as determined by the answer to the question, “Have you
smoked at least 100 cigarettes in your entire life?”;
current smoking status based on the question, “Do you
now smoke cigarettes?”; self-reported stress values
collected through two questions asking the participants,
“Now thinking about your mental health, which includes
stress, depression, and problems with emotions, for how
many days during the past 30 days was your mental
health not good?” and “During the past 30 days, for
about how many days have you felt worried, tense, or
anxious?”; vitamin D serum levels; annual household
income; and educational level.
For the multivariate analysis, the confounders taken into
account were the ones with statistical significance in the
univariate analysis and a strong association with the epi-
demiology of the disease—age and gender. The main out-
come was considered to be a clinical diagnosis of uveitis
based on the participant’s answer to the question above.
Statistical analysis
We used RStudio (version 0.99.903, RStudio, Inc.,
Boston, MA) for our statistical analyses. NHANES is a
complex designed survey which takes into account non-
response rate and post-stratification. When a sample is
weighted in NHANES, it is representative of the US
census noninstitutionalized civilian population. In order
to produce adequate statistical reliability, analysis was
performed using weighting for subsets of the data. The
distribution of possible confounding variables was com-
pared between the participants with and without uveitis
diagnosis using Rao–Scott–Pearson χ2 and Wald tests
for categorical and continuous variables, respectively.
A multivariate logistic regression model analysis was
performed in order to determine the odds of self-
reported uveitis among the different ethnic groups, the
presence or absence of a diagnosis of ankylosing spon-
dylitis, a positive smoking history, and the mental health
and stress values, adjusting for the confounding vari-
ables: age and gender. Additional sub-population ana-
lyses were done regarding the association between
uveitis and vitamin D deficiency, annual household in-
come, and educational level. The calculation of the
prevalence estimate of uveitis in our population was
survey-weighted. All analyses are accounted for the
complex multi-stage design of the NHANES.
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